J&J Expands Damages In Express2 Injunction Bid; BSC Adds Counterclaims

Claims made by Johnson & Johnson/Cordis' legal counsel arguing a patent infringement case against Boston Scientific/Scimed may be further buttressed by previous actions taken by a Delaware district court

More from Archive

More from Medtech Insight